ChemiDoc™ MP Imaging System
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The National Institutes of Health (NIH) is soliciting quotes for a ChemiDoc™ MP Imaging System for Dr. Chittiboina's research lab in Bethesda, MD. This is a Combined Synopsis/Solicitation for a Firm Fixed-Price contract. Quotes are due June 15, 2026, at 9:00 AM EDT.
Scope of Work
The requirement is for one ChemiDoc™ MP Imaging System (Bio-Rad, Catalog # 12003154), including specific reagents (StarBright Blue 700 Goat Anti-Rabbit IgG and hFAB™ Rhodamine Anti-Tubulin Primary Antibody). This system is crucial for reliably documenting and quantifying results from routine molecular biology workflows, such as chemiluminescent and fluorescent blot imaging and gel documentation. It will provide high-sensitivity, reproducible imaging for accurate data capture, compliance-ready recordkeeping, and efficient experiment throughput, enhancing the lab's capability to standardize imaging conditions and improve quantitative accuracy.
Contract & Timeline
- Type: Combined Synopsis/Solicitation (RFQ), Firm Fixed Price
- Set-Aside: None (Unrestricted)
- NAICS: 334516 (Laboratory Equipment And Supplies)
- Response Due: June 15, 2026, 9:00 AM EDT
- Published: May 29, 2026
- Delivery: As soon as possible, within 7 days of award
- Place of Performance: Bethesda, MD
Evaluation
Award will be made to the responsible offeror whose quote is most advantageous to the Government, considering Technical capability, Past Performance, and Cost. Technical and Past Performance, when combined, are significantly more important than Cost.
Additional Notes
This acquisition is for a brand-name item, the ChemiDoc™ MP Imaging System, manufactured solely by Bio-Rad. The agency prefers Bio-Rad due to a more competitive price compared to other vendors. This solicitation is conducted under FAR Parts 12 and 13. Offerors must include a completed FAR clause 52.212-3 and acknowledge all addenda.